JP2017526696A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017526696A5 JP2017526696A5 JP2017512683A JP2017512683A JP2017526696A5 JP 2017526696 A5 JP2017526696 A5 JP 2017526696A5 JP 2017512683 A JP2017512683 A JP 2017512683A JP 2017512683 A JP2017512683 A JP 2017512683A JP 2017526696 A5 JP2017526696 A5 JP 2017526696A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- cancer
- alkyl
- heterocyclyl
- carbocyclyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JRSIQYMBIOYIKI-CMPLNLGQSA-N CC(C)N[C@@H](C)[C@H](c1c[n](C)nc1)N(C)C Chemical compound CC(C)N[C@@H](C)[C@H](c1c[n](C)nc1)N(C)C JRSIQYMBIOYIKI-CMPLNLGQSA-N 0.000 description 1
- ZVAIRWNDOBFCGA-UHFFFAOYSA-N CNCC(c1ccccc1Cl)N(C)C Chemical compound CNCC(c1ccccc1Cl)N(C)C ZVAIRWNDOBFCGA-UHFFFAOYSA-N 0.000 description 1
- YLYKWCBMDLKEJG-UHFFFAOYSA-N CNCCN(C)CCOC Chemical compound CNCCN(C)CCOC YLYKWCBMDLKEJG-UHFFFAOYSA-N 0.000 description 1
- GYGYDOOXVKDZCF-UHFFFAOYSA-N CNCCN1CCCC1 Chemical compound CNCCN1CCCC1 GYGYDOOXVKDZCF-UHFFFAOYSA-N 0.000 description 1
- KCAUHAHOMIRXAN-UHFFFAOYSA-N CNCCN1CCCCC1 Chemical compound CNCCN1CCCCC1 KCAUHAHOMIRXAN-UHFFFAOYSA-N 0.000 description 1
- FIHCABIMANEXHV-UHFFFAOYSA-N CNNCC(c1ccccc1F)N(C)C Chemical compound CNNCC(c1ccccc1F)N(C)C FIHCABIMANEXHV-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462046756P | 2014-09-05 | 2014-09-05 | |
| US62/046,756 | 2014-09-05 | ||
| PCT/US2015/048354 WO2016036954A1 (en) | 2014-09-05 | 2015-09-03 | Phthalazine derivatives of formula (i) as pcaf and gcn5 inhibitors for use in the treatment of cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017526696A JP2017526696A (ja) | 2017-09-14 |
| JP2017526696A5 true JP2017526696A5 (enExample) | 2018-10-11 |
| JP6767969B2 JP6767969B2 (ja) | 2020-10-14 |
Family
ID=54266610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017512683A Expired - Fee Related JP6767969B2 (ja) | 2014-09-05 | 2015-09-03 | がんの処置における使用のためのｐｃａｆおよびｇｃｎ５阻害剤としての式（ｉ）のフタラジン誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10155764B2 (enExample) |
| EP (1) | EP3189049B1 (enExample) |
| JP (1) | JP6767969B2 (enExample) |
| CN (1) | CN107074824B (enExample) |
| WO (1) | WO2016036954A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6814730B2 (ja) | 2014-09-05 | 2021-01-20 | ジェネンテック， インコーポレイテッド | 治療用化合物およびその使用 |
| JP6598286B2 (ja) * | 2014-12-05 | 2019-10-30 | 国立大学法人東京工業大学 | チロシンの修飾方法 |
| EP3242874B1 (en) | 2015-01-09 | 2018-10-31 | Genentech, Inc. | Pyridazinone derivatives and their use in the treatment of cancer |
| AU2018209164B2 (en) | 2017-01-17 | 2021-11-04 | Heparegenix Gmbh | Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death |
| CN108196068B (zh) * | 2018-01-29 | 2019-09-10 | 武汉大学 | 血管紧张素转化酶启动子区组蛋白乙酰化在制备改善胎源性成年骨质疏松症药物中的应用 |
| KR102085758B1 (ko) * | 2019-08-05 | 2020-03-06 | 연세대학교 산학협력단 | 히스톤 아세틸트렌스퍼라제 p300 억제용 신규 화합물 및 이를 포함하는 항섬유화 조성물 |
| JP2023511472A (ja) * | 2019-10-29 | 2023-03-20 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | がんの治療のための二官能性化合物 |
| WO2022026465A1 (en) * | 2020-07-28 | 2022-02-03 | Mirati Therapeutics, Inc. | Sos1 inhibitors |
| KR20230137286A (ko) | 2020-09-11 | 2023-10-04 | 미라티 테라퓨틱스, 인크. | Kras g12c 억제제의 결정 형태 |
| TWI880049B (zh) * | 2020-12-04 | 2025-04-11 | 美商美國禮來大藥廠 | Kras g12c抑制劑 |
| EP4262807A4 (en) | 2020-12-15 | 2025-04-23 | Mirati Therapeutics, Inc. | Azachinazoline pan-KRAS inhibitors |
| US11999753B2 (en) | 2020-12-16 | 2024-06-04 | Mirati Therapeutics, Inc. | Tetrahydropyridopyrimidine pan-KRas inhibitors |
| CN116635371B (zh) * | 2021-02-09 | 2025-08-26 | 苏州阿尔脉生物科技有限公司 | 一种作为sos1抑制剂的多环哒嗪酮类衍生物、其制备方法及用途 |
| JP2024521818A (ja) * | 2021-05-27 | 2024-06-04 | シュレーディンガー， インコーポレイテッド | ヘテロ環式化合物およびその使用方法 |
| JP2025530801A (ja) | 2022-09-02 | 2025-09-17 | オーロン セラピューティクス，インコーポレーテッド | 増殖性障害を処置するためのｋａｔ２分解誘導薬としてのピリダジノン誘導体 |
| CN119504796A (zh) * | 2024-11-20 | 2025-02-25 | 南通大学附属医院 | 一种具有抗肿瘤活性的化合物及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB808636A (en) * | 1955-08-02 | 1959-02-11 | Cassella Farbwerke Mainkur Ag | Basically substituted heterocyclic compounds |
| JPS4931683A (enExample) * | 1972-07-27 | 1974-03-22 | ||
| FR2707294B1 (fr) | 1993-07-06 | 1995-09-29 | Pf Medicament | Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine. |
| EP1423120A4 (en) * | 2001-08-15 | 2005-12-28 | Icos Corp | 2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF |
| EP1732541A4 (en) * | 2004-04-07 | 2008-03-05 | Takeda Pharmaceutical | CYCLIC COMPOUNDS |
| CN1980674B (zh) * | 2004-06-30 | 2011-05-25 | 詹森药业有限公司 | 作为parp抑制剂的2,3-二氮杂萘衍生物 |
| JP2013528180A (ja) | 2010-05-28 | 2013-07-08 | ジーイー・ヘルスケア・リミテッド | 放射性標識化合物及びその製造方法 |
| KR101422725B1 (ko) * | 2011-10-19 | 2014-07-25 | 한국화학연구원 | 신규한 프탈라지논 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 ｍｃｈ 수용체-1 관련 질환의 예방 또는 치료용 약학적 조성물 |
| UY35103A (es) * | 2012-10-29 | 2014-05-30 | Glaxo Group Ltd | Compuestos de cefem 2-sustituidos |
| US9200005B2 (en) * | 2013-03-13 | 2015-12-01 | AbbVie Deutschland GmbH & Co. KG | Inhibitor compounds of phosphodiesterase type 10A |
| US20160024504A1 (en) | 2013-03-15 | 2016-01-28 | Constellation Pharmaceuticals, Inc. | Treating th2-mediated diseases by inhibition of bromodomains |
| JP6814730B2 (ja) | 2014-09-05 | 2021-01-20 | ジェネンテック， インコーポレイテッド | 治療用化合物およびその使用 |
| EP3242874B1 (en) | 2015-01-09 | 2018-10-31 | Genentech, Inc. | Pyridazinone derivatives and their use in the treatment of cancer |
-
2015
- 2015-09-03 CN CN201580059719.5A patent/CN107074824B/zh not_active Expired - Fee Related
- 2015-09-03 JP JP2017512683A patent/JP6767969B2/ja not_active Expired - Fee Related
- 2015-09-03 EP EP15777756.6A patent/EP3189049B1/en active Active
- 2015-09-03 WO PCT/US2015/048354 patent/WO2016036954A1/en not_active Ceased
-
2017
- 2017-03-03 US US15/449,692 patent/US10155764B2/en active Active